retatrutide 2025 trial results This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond eli lilly retatrutide press release

V.MeierD

A pesar de la baja incidencia de estos eventos adversos y de la probabilidad de que los beneficios superen estos riesgos en los individuos con obesidad grave, los mdicos y los pacientes deben ser conscientes de estos efectos secundarios graves

What Makes This Formula Special

[ Editor's note: After MH went to press, Jelly clarified that he did briefly try weight-loss meds very early on his journey, but stopped after two weeks.] We talked for several hours at intervals over the course of this year about how he was doing it, and how he did it

Potential Risks: Conversely, other studies indicate that GLP-1 receptor agonists might increase the risk of developing colorectal cancer

Brands are responsible for ensuring their products are safe and do not have to prove scientific benefits before selling their products." This lack of FDA oversight has raised red flags for potential customers